Harnessing Data Science for Health Discovery and Innovation in Africa (DS-I Africa) Research Hubs (U54 Clinical Trial Optional)
The summary for the Harnessing Data Science for Health Discovery and Innovation in Africa (DS-I Africa) Research Hubs (U54 Clinical Trial Optional) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Harnessing Data Science for Health Discovery and Innovation in Africa (DS-I Africa) Research Hubs (U54 Clinical Trial Optional): This Funding Opportunity Announcement (FOA) seeks applications for Research Hubs as part of a broader initiative entitled Harnessing Data Science for Health Discovery and Innovation in Africa (DS-I Africa). The goal of DS-I Africa is to spur new health discoveries and catalyze innovation in healthcare, public health, and health research on the continent through application of data science. DS-I Africa Research Hubs will be funded to advance data science health research and innovation in Africa and support new African and global partnerships that enhance the impact of data science health research. Hubs will engage government, industry, or other organizations, including diverse departments from academic institutions, that can partner to provide synergistic expertise, collaborate on research, and support data science linked to new technologies and solutions. Applicants must propose at least 2 distinct research projects and a system for soliciting, evaluating, and awarding smaller pilots projects, all focused on a central health theme that addresses priorities in an African country or region. Applications must be submitted from African academic or other non-profit organizations. Proposed partnerships with organizations outside the applicant institution are required and can include all types of organizations in Africa, the U.S., or other countries.
Federal Grant Title: | Harnessing Data Science for Health Discovery and Innovation in Africa (DS-I Africa) Research Hubs (U54 Clinical Trial Optional) |
Federal Agency Name: | National Institutes of Health (HHS-NIH11) |
Grant Categories: | Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | RFA-RM-20-015 |
Type of Funding: | Cooperative Agreement |
CFDA Numbers: | 93.310 |
CFDA Descriptions: | Information not provided |
Current Application Deadline: | February 8th, 2021 |
Original Application Deadline: | February 8th, 2021 |
Posted Date: | July 24th, 2020 |
Creation Date: | July 24th, 2020 |
Archive Date: | March 16th, 2021 |
Total Program Funding: | |
Maximum Federal Grant Award: | |
Minimum Federal Grant Award: | |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
Last Updated: | July 24th, 2020 |
- Applicants Eligible for this Grant
- Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education
- Additional Information on Eligibility
- Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
- Link to Full Grant Announcement
- http://grants.nih.gov/grants/guide/rfa-files/RFA-RM-20-015.html
- Grant Announcement Contact
- NIH OER Webmaster
[email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster - Similar Government Grants
- • Pilot Projects Enhancing Utility and Usage of Common Fund Data Sets (R03 Clinical Trial No...
- • Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allow...
- • NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)
- • NIH Directors Early Independence Awards (DP5 Clinical Trial Optional)
- • NIH Directors New Innovator Award Program (DP2 Clinical Trial Optional)
- • Using Metabolomics to Investigate Biological Pathways and Networks (R01)
- • Assay Development for High Throughput Molecular Screening (R21)
- • Membrane Protein Production and Structure Determination (R01)
- More Grants from the National Institutes of Health
- • SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies...
- • Small Business Transition Grant For Early Career Scientists (R41/R42 Clinical Trial Not Al...
- • Cystic Fibrosis Research and Translation Centers (P30 Clinical Trial Optional)
- • Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial No...
- • Mentored Quantitative Research Development Award (Parent K25 Independent Basic Experimenta...